Research Explorer

Your browser does not support JavaScript or JavaScript is not enabled. Without JavaScript some functions of this webapplication may be disabled or cause error messages. To enable JavaScript, please consult the manual of your browser or contact your system administrator.

Project

Development and use of new genetic engineering and testing for BCG-based anti-tuberculosis vaccines

Outputs and Outcomes

Code

178WE1715

Duration

01 January 2015 → 31 December 2018

Funding

Regional and community funding: IWT/VLAIO

Promotor

Nico Callewaert

Fellow

Katlyn Borgers

Research disciplines

Natural sciences
- Microbiology not elsewhere classified
- Systems biology not elsewhere classified
Medical and health sciences
- Laboratory medicine not elsewhere classified
- Microbiology not elsewhere classified
- Laboratory medicine not elsewhere classified
- Laboratory medicine not elsewhere classified
- Microbiology not elsewhere classified

Keywords

tuberculosis vaccins

Project description

The abstract for "Development and use of new genetic engineering and testing for BCG-based anti-tuberculosis vaccines" is missing. Please contact the promotor for more information.

English

Dutch

English

Cookie settings

In addition to functional cookies which are necessary for the website to function, Ghent University uses non-functional cookies such as statistical cookies and social media cookies. These non-functional cookies can also be placed by third parties, for example to measure the use of the site or to share content on social media. Certain media are only available if you accept the cookies. You can set and modify your cookie preferences yourself. Find out what cookies we use and why in the Cookie Statement.

Analytics

AnalyticsWe'll collect information about your visit to our site. It helps us understand how the site is used – what's working, what might be broken and what we should improve.

Powered by